CHEK2 and ductal breast carcinoma in situ: Only CHEK2 mutations predisposed to DCIS, therefore we investigated their influence on age of DCIS diagnosis, the impact on survival among patients, and the effect of positive family history of breast cancer in CHEK2 carriers on the risk of DCIS.